TGFB1 and neoplasm: Fluorescent silica nanoparticles marked by endoglin aptamers have been demonstrated to interfere with the TGF-β pathway by binding to tumour vascular endothelial cell membrane proteins, further inhibiting angiogenesis and reducing vascular density in xenograft hepatocellular carcinoma mice (133).